TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/14/2023
Back to search
Official data from USPTO
ASKLEPION PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ASKLEPION PHARMACEUTICALS
ST13
US500000077232242Class
42
Filing
77232242
Registration
3525208
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
03/14/2023
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
07/18/2007
Registration date
10/28/2008
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/29/2018
Last transaction
02/24/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/01/2006
First use in commerce
04/01/2006
Drawing code
4
Owner type
16
Owner location
Baltimore, MD
Examiner
LITZAU,MICHAEL
Law office
L40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Asklepion Pharmaceuticals, LLC
Asklepion Pharmaceuticals, LLC
Representatives
Tara Aaron-Stelluto BARTON LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
55 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/14/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/23/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/23/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/23/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/11/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/11/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/11/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/29/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/29/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/29/2018
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
10/29/2018
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/29/2018
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
10/27/2018
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/25/2018
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
10/24/2018
ES7R
TEAS SECTION 7 REQUEST RECEIVED
10/17/2018
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/17/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/21/2017
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
11/30/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/30/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
11/02/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/28/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/27/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/05/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/05/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/03/2014
E815
TEAS SECTION 8 & 15 RECEIVED
10/23/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/23/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/11/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/17/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
10/28/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
09/24/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/24/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/22/2008
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/22/2008
IUAF
USE AMENDMENT FILED
09/18/2008
EISU
TEAS STATEMENT OF USE RECEIVED
09/18/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
03/18/2008
PUBO
PUBLISHED FOR OPPOSITION
12/25/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/06/2007
NPUB
NOTICE OF PUBLICATION
12/05/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/30/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/16/2007
ALIE
ASSIGNED TO LIE
11/16/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/15/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
10/15/2007
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/15/2007
GNEA
EXAMINERS AMENDMENT E-MAILED
10/15/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/15/2007
DOCK
ASSIGNED TO EXAMINER
10/03/2007
NWAP
NEW APPLICATION ENTERED
07/23/2007
Continuous trademark protection
Get notified about every new filing that threatens ASKLEPION PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.